These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 1627786)

  • 1. Tumor necrosis factor and interferon gamma: relevance for immune regulation and genetic predisposition to autoimmune disease.
    Jacob CO
    Semin Immunol; 1992 Jun; 4(3):147-54. PubMed ID: 1627786
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic variability in tumor necrosis factor production: relevance to predisposition to autoimmune disease.
    Jacob CO
    Reg Immunol; 1992; 4(5):298-304. PubMed ID: 1290749
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhanced autoimmune arthritis in IFN-gamma receptor-deficient mice is conditioned by mycobacteria in Freund's adjuvant and by increased expansion of Mac-1+ myeloid cells.
    Matthys P; Vermeire K; Mitera T; Heremans H; Huang S; Schols D; De Wolf-Peeters C; Billiau A
    J Immunol; 1999 Sep; 163(6):3503-10. PubMed ID: 10477624
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intrinsic defects in macrophage IL-12 production associated with immune dysfunction in the MRL/++ and New Zealand Black/White F1 lupus-prone mice and the Leishmania major-susceptible BALB/c strain.
    Alleva DG; Kaser SB; Beller DI
    J Immunol; 1998 Dec; 161(12):6878-84. PubMed ID: 9862720
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immuno- and genetic therapy in autoimmune diseases.
    Chernajovsky Y; Dreja H; Daly G; Annenkov A; Gould D; Adams G; Croxford JL; Baker D; Podhajcer OL; Mageed RA
    Genes Immun; 2000 Jun; 1(5):295-307. PubMed ID: 11196690
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vivo apoptosis of diabetogenic T cells in NOD mice by IFN-gamma/TNF-alpha.
    Qin HY; Chaturvedi P; Singh B
    Int Immunol; 2004 Dec; 16(12):1723-32. PubMed ID: 15492021
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Defective major histocompatibility complex class I expression on lymphoid cells in autoimmunity.
    Fu Y; Nathan DM; Li F; Li X; Faustman DL
    J Clin Invest; 1993 May; 91(5):2301-7. PubMed ID: 8486790
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytokine-based immunomodulation of autoimmune diseases: an overview.
    Bach JF
    Transplant Proc; 1996 Dec; 28(6):3023-5. PubMed ID: 8962173
    [No Abstract]   [Full Text] [Related]  

  • 9. Autoimmune disorders in diabetes.
    Boitard C; Debray-Sachs M; Bach JF
    Adv Nephrol Necker Hosp; 1986; 15():281-305. PubMed ID: 3082114
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Studies on the role of tumor necrosis factor in murine and human autoimmunity.
    Jacob CO
    J Autoimmun; 1992 Apr; 5 Suppl A():133-43. PubMed ID: 1503608
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased circulating CD11b+CD11c+ dendritic cells (DC) in aged BWF1 mice which can be matured by TNF-alpha into BLC/CXCL13-producing DC.
    Ishikawa S; Nagai S; Sato T; Akadegawa K; Yoneyama H; Zhang YY; Onai N; Matsushima K
    Eur J Immunol; 2002 Jul; 32(7):1881-7. PubMed ID: 12115607
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The protective effect of IFN-gamma in experimental autoimmune diseases: a central role of mycobacterial adjuvant-induced myelopoiesis.
    Matthys P; Vermeire K; Heremans H; Billiau A
    J Leukoc Biol; 2000 Oct; 68(4):447-54. PubMed ID: 11037964
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lpr and MRL background gene involvement in the control of adjuvant enhanced arthritis in MRL-lpr mice.
    Ratkay LG; Tait B; Tonzetich J; Waterfield JD
    J Autoimmun; 1994 Oct; 7(5):561-73. PubMed ID: 7530961
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of MHC class II antigen expression. Opposing effects of tumor necrosis factor-alpha on IFN-gamma-induced HLA-DR and Ia expression depends on the maturation and differentiation stage of the cell.
    Watanabe Y; Jacob CO
    J Immunol; 1991 Feb; 146(3):899-905. PubMed ID: 1899098
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IFN-gamma receptor signaling is essential for the initiation, acceleration, and destruction of autoimmune kidney disease in MRL-Fas(lpr) mice.
    Schwarting A; Wada T; Kinoshita K; Tesch G; Kelley VR
    J Immunol; 1998 Jul; 161(1):494-503. PubMed ID: 9647261
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protooncogenes and autoimmunity.
    Rapoport M; Mor A; Bistritzer T; Ramot Y; Levi O; Slavin S; Wysenbeek A
    Isr J Med Sci; 1997 Apr; 33(4):262-6. PubMed ID: 9347876
    [No Abstract]   [Full Text] [Related]  

  • 17. Humanized animal models for autoimmune diseases.
    Gregersen JW; Holmes S; Fugger L
    Tissue Antigens; 2004 May; 63(5):383-94. PubMed ID: 15104670
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Utility of murine models for the study of spontaneous autoimmune type 1 diabetes.
    Mathews CE
    Pediatr Diabetes; 2005 Sep; 6(3):165-77. PubMed ID: 16109074
    [No Abstract]   [Full Text] [Related]  

  • 19. Autoimmunity induction by human T cell leukemia virus type 1 in transgenic mice that develop chronic inflammatory arthropathy resembling rheumatoid arthritis in humans.
    Iwakura Y; Saijo S; Kioka Y; Nakayama-Yamada J; Itagaki K; Tosu M; Asano M; Kanai Y; Kakimoto K
    J Immunol; 1995 Aug; 155(3):1588-98. PubMed ID: 7636219
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oncogene expression in autoimmune mice.
    Mountz JD; Mushinski JF; Mark GE; Steinberg AD
    J Mol Cell Immunol; 1985; 2(3):121-31. PubMed ID: 3916923
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.